Predicting Success in Regulatory Approval from Phase I Results

TY - JOUR

T1 - Predicting Success in Regulatory Approval from Phase I Results

AU - Mejia Garcia, Alex V.

AU - and institutional affiliations, Additional authors

N1 - These preliminary findings indicate that objective responses in Phase I trials may have predictive value for later regulatory approval. Malik, L., Mejia, A., Parsons, H., Ehler, B., Mahalingam, D., Brenner, A., Sarantopoulos, J., & Weitman, S. (2014). Predicting success in regulatory approval from Phase I results. Cancer chemotherapy and pharmacology, 74(5), 1099–1103. https://doi.org/10.1007/s00280-014-2596-4

PY - 2014

Y1 - 2014

UR - https://pubmed.ncbi.nlm.nih.gov/25245822/

M3 - Article

VL - 74

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

ER -